SCHEME 1.
Metal‐based nanomaterials with anti‐tumor biological effects in cancer therapy for metal‐enhanced radiotherapy sensitization, metal‐enhanced catalytic therapy, metal‐enhanced ferroptosis, metal‐enhanced pyroptosis, and metal‐enhanced immunotherapy.